The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Dubai Airports: Over 1,140 flights facilitated in past 84 hours
UAE Attorney-General reminds residents not to share misleading videos
Mohammed Al Sharqi visits Fujairah Oil Industry Zone, praises field teams
RTA opens 2 bridges linking Al Asayel to Al Khail Road
